BERINERT 1500 1500 UNIT
C1 ESTERASE INHIBITOR (HUMAN) : 1500 UNIT · DIN 02436078 · CSL BEHRING CANADA INC
Health Canada status: MARKETED
What is BERINERT 1500?
BERINERT 1500 1500 UNIT contains C1 ESTERASE INHIBITOR (HUMAN) : 1500 UNIT. It is listed in the Health Canada Drug Product Database under DIN 02436078, held by CSL BEHRING CANADA INC, supplied as KIT ; POWDER FOR SOLUTION for INTRAVENOUS administration. Health Canada currently lists it as marketed, status dated 06-May-2015. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02436078 |
|---|---|
| Brand name | BERINERT 1500 |
| Generic / active ingredient | C1 ESTERASE INHIBITOR (HUMAN) : 1500 UNIT |
| Manufacturer | CSL BEHRING CANADA INC |
| Strength | 1500 UNIT |
| Dosage form | KIT ; POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS |
| Schedule | Schedule D |
| ATC code | B06AC01 C1-INHIBITOR, PLASMA DERIVED |
| AHFS class | 92:32.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 06-May-2015 |
| Original market date | 2015-05-06 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code B06AC01 C1-INHIBITOR, PLASMA DERIVED. 4 of 5 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| BERINERT 500 | 500 UNIT | KIT ; POWDER FOR SOLUTION | CSL BEHRING CANADA INC | MARKETED | DIN 02352575 |
| HAEGARDA | 2000 UNIT | POWDER FOR SOLUTION ; KIT | CSL BEHRING CANADA INC | MARKETED | DIN 02468069 |
| HAEGARDA | 3000 UNIT | KIT ; POWDER FOR SOLUTION | CSL BEHRING CANADA INC | MARKETED | DIN 02468077 |
| CINRYZE | 500 UNIT | POWDER FOR SOLUTION | TAKEDA CANADA INC | CANCELLED POST MARKET | DIN 02395371 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.